Syra Health Earnings Call Transcripts
Fiscal Year 2025
-
Q1 2025 revenue grew 6% year-over-year to $1.9 million, led by a 261% surge in population health. Gross margin expanded to 31.7% and net loss improved by over two-thirds, but federal funding uncertainty led to withdrawal of full-year guidance.
Fiscal Year 2024
-
2024 revenue grew 45% to $8 million, driven by strong gains in population health and healthcare workforce units. Gross margin declined due to revenue mix, but cost controls halved Q4 net loss. 2025 guidance calls for low double-digit revenue growth and continued margin improvement.
-
Q3 2024 saw 42% year-over-year revenue growth, improved gross margins, and a 69% sequential reduction in net loss, driven by high-margin business units and cost optimization. New contracts, product launches, and a $2.1M capital raise support a strong outlook toward profitability in 2025.